MLB sued Biogenesis and its operators in a Florida court in March, an attempt to pressure Bosch. A person familiar with the case told The Associated Press on Tuesday night that Bosch agreed to talk to MLB, a deal first reported by ESPN. MLB wants to speak with Bosch in the next few days,
"Due to ongoing litigation, it would be inappropriate to comment on any aspect of this matter at this time," Bosch's lawyer, Susy Ribero-Ayala, said in a statement.
Among the players linked to the clinic, Cabrera, Colon and San Diego catcher Yasmani Grandal already have served 50-game suspensions following positive tests for testosterone announced by MLB last year.
"It looks like it could be getting to the bottom of this and finding some information that hopefully would help Major League Baseball as far as cleaning this game up," said San Francisco manager Bruce Bochy, who managed Cabrera last year. "I always thought they should be a little stricter to keep these players from trying to beat the system and cheat. I'm all for stiffer penalties."
Once MLB interviews Bosch and the players, it will have to determine what penalties to impose.
"WADA commends the decision of Major League Baseball to seek suspension of an estimated 20 players," World Anti-Doping Agency Director General David Howman said in a statement.
"More and more, information and evidence gathered in the investigative process is proving an effective means of uncovering doping in sport. MLB has approached this issue in a professional way, and the evidence gathered will undoubtedly be pivotal," Howman said.
Any suspensions for first offenders would be put on hold if the union files a grievance, a process that would put the matter in front of an arbitrator and delay possible sanctions for weeks or months. Second offenders would serve suspensions during the grievance process.